SCHEMBL2126223

SCHEMBL2126223

CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](CO)OP(=O)(O)O

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.73
PRKCE Q02156 1/20 0.73
PRKCQ Q04759 1/20 0.73
PRKCD Q05655 1/20 0.73
ENPP2 Q13822 4/20 0.70
LPAR1 Q92633 6/20 0.65
LPAR3 Q9UBY5 3/20 0.65
LPAR4 Q99677 2/20 0.65
LPAR5 Q9H1C0 2/20 0.65
LPAR2 Q9HBW0 2/20 0.65
CES2 O00748 1/20 0.65
LPAR6 P43657 1/20 0.65
TRPV1 Q8NER1 1/20 0.65
DGKA P23743 1/20 0.64
S1PR1 P21453 1/20 0.63
RECQL P46063 1/20 0.62
BLM P54132 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
SELP P16109 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8002666 1.00 PRKCA (0.73) PRKCAPRKCEPRKCQPRKCDENPP2
SCHEMBL8911249 1.00 PRKCA (0.73) PRKCAPRKCEPRKCQPRKCDENPP2
SCHEMBL64083 0.99 PRKCA (0.71) PRKCAPRKCEPRKCQPRKCDENPP2
Glycerin SCHEMBL28136461 0.95 DGKA (0.70) PRKCAPRKCEPRKCQPRKCDENPP2
SCHEMBL30668211 0.94 ENPP2 (0.75) PRKCAPRKCEPRKCQPRKCDENPP2
SCHEMBL2125352 0.93 FAAH (0.66) PRKCAPRKCEPRKCQPRKCDENPP2
SCHEMBL8910338 0.92 PRKCA (0.68) PRKCAPRKCEPRKCQPRKCDENPP2
SCHEMBL8911157 0.92 PRKCA (0.68) PRKCAPRKCEPRKCQPRKCDENPP2
SCHEMBL8910329 0.92 PRKCA (0.68) PRKCAPRKCEPRKCQPRKCDENPP2
SCHEMBL19433866 0.92 PRKCA (0.68) PRKCAPRKCEPRKCQPRKCDENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012052539-A1 NOVEL NEUTRAL (BIO)MATERIAL CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2012-04-26 WO claimed
EP-2444464-A1 Novel neutral (bio)material Centre National de la Recherche Scientifique (CNRS) (FR) 2012-04-25 EP claimed
WO-2012052539-A1 NOVEL NEUTRAL (BIO)MATERIAL CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2012-04-26 WO disclosed
EP-2444464-A1 Novel neutral (bio)material Centre National de la Recherche Scientifique (CNRS) (FR) 2012-04-25 EP disclosed
US-20100239501-A1 GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF RIKEN (JP) 2010-09-23 US disclosed
EP-2153847-A1 GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF Riken (JP) 2010-02-17 EP disclosed
US-6344342-B1 AN ISOLATED POLYNUCLEOTIDE ENCODING A POLYPEPTIDE; DIAGNOSIS AND THERAPY FOR INFECTIONS CAUSED BY HIV-1 OR HIV-2, CANCERS, DIABETES, ASTHMA, PARKINSON'S DISEASE, ULCERS, ALLERGIES, CONGESTIVE HEART FAILURE, KIDNEY DISEASES, SEXUAL DISORDERS SMITHKLINE BEECHAM CORPORATION 2002-02-05 US disclosed
US-6242572-B1 AMINO ACID SEQUENCE OF POLYPEPTIDE; ANTICARCINOGENIC AGENTS; ANTIDIABETIC AGENTS; HYPOTENSIVE/HYPERTENSIVE AGENTS; ANTIULCER AGENTS; TREATMENT OF NERVOUS SYSTEM DISORDERS, SLEEP DISORDERS, GLANDULAR DISORDERS AND OTHERS; DIAGNOSIS SMITHKLINE BEECHAM CORPORATION 2001-06-05 US disclosed